Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
about
Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic DiseasesThe epidemiology of venous thromboembolismHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationThromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.Contemporary treatment of immune thrombocytopenia.Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia.Immune thrombocytopenia: recent progress in pathophysiology and treatment.Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.A review of the management of childhood immune thrombocytopenia: how can we provide an evidence-based approach?Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.Is ITP a thrombophilic disorder?Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study.Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies.Long-term results of splenectomy in adult chronic immune thrombocytopenia.Low-level light treatment ameliorates immune thrombocytopenia.Long-term complications of splenectomy in adult immune thrombocytopenia.Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect.State of the art - how I manage immune thrombocytopenia.Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.Fatal pulmonary embolism following splenectomy in a patient with Evan's syndrome: case report and review of the literature.Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutationsRole of the hemostatic system on sickle cell disease pathophysiology and potential therapeuticsEpidemiology of venous thromboembolism.Thrombopoietin receptor agonists (TPO-RAs) in patients with persistent or chronic immune thrombocytopenia (ITP).Splenectomy for Immune Thrombocytopenia: Down but not out.Immune thrombocytopenia - in defence of the platelet count. Response to Hill.Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a meta-analysis.Physician Decision Making in Selection of Second-Line Treatments in Immune Thrombocytopenia in Children.Multiple total hip arthroplasties in refractory immune thrombocytopenic purpura: A case report and literature review.Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease.The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review.Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
P2860
Q26778773-C895AC11-C7F0-4DEF-A5DA-93A35C42ECB5Q28067893-6C681E01-3F5E-4A7E-9CAE-D0DA2D199E73Q29547691-73964B14-B37D-4C3F-8BBE-18CBEE879F6AQ30250259-1F8AA0CE-9E40-4FF8-843E-041A6CE2053FQ33410348-8B26DC9E-6B3E-493D-8AF7-DAF191DA1763Q33410653-CE643639-F5F5-4FF0-B093-F639D65EE87FQ33412923-9296A123-A3CE-44AC-A2BF-56B40DC5C474Q33413896-C501A72A-3659-4E5A-8F53-08D12C8BEA78Q33414722-EE0F3A11-7B03-4407-A517-5702AB50AC77Q33414825-FAC57AF7-CA3B-40D6-BAC0-E31AF4017092Q33415996-3F5C3EC1-9EC3-4846-B006-BC9A0F6483AFQ33427394-DFDACDEC-489A-4BC1-9728-3D5D7F2CA210Q33427488-7324C9CB-C3B3-40C8-8E97-D17F551A4011Q33429426-09E66C24-A364-466C-9A1C-85BE285DA5DCQ33430258-14F683BA-C3D8-4321-9A95-FFD9C8F047D7Q33431551-4E959F0D-6918-45CE-8A66-BE763FE7E0EAQ33436100-D7282ABD-6412-4656-9829-C4FB3D47056DQ33437208-EF431180-A55B-4BE6-A5C0-CC2635D3E046Q33437227-2356551D-CEEE-43FF-9D86-184732D3057EQ33437682-AD07974F-E5FC-43A4-8602-FF32E48222C4Q33438334-FD30BB92-B755-4335-AF8F-194926164F20Q33440145-63068506-D06A-4565-983B-B578A2E85747Q33441008-3CA40942-D73C-4653-A39C-35392CC57562Q33443338-81A1BB86-15F2-4587-83B5-47D92A972744Q37670054-5E0ED9F0-FC47-4708-A167-7E91D4363B1DQ37700095-3ECE9D90-5043-495E-A09A-B014164BAAC0Q41667853-81B51A0F-697C-4545-A91F-004936A26219Q47305608-C397DC6D-AF93-425A-AF78-8670570EB010Q47754303-E63DE034-05DD-4055-AF08-9C3E5488A2CEQ48179360-1A6D1AA6-AFC3-4AFF-807D-8FB286BF3C7DQ50224066-A6B571B0-6B5C-476A-A372-0188E4B0BB46Q52320502-A019E526-FF9C-4E7B-86BB-0967D2B0B32CQ52593852-44003458-5981-4934-8262-781D6136EE6BQ52633900-D1CFD953-6353-4A1D-8CC6-EB959AF1851DQ52889515-AD9D6AE1-7E26-41F6-BB02-02BE8BCB3D23Q55334988-00E75F07-BB85-4BD8-B0DD-ACF989917695Q59135184-3B8C8006-4C2F-4C7A-9FD1-D7D72F48AB4C
P2860
Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Splenectomy and the incidence ...... s with immune thrombocytopenia
@ast
Splenectomy and the incidence ...... s with immune thrombocytopenia
@en
type
label
Splenectomy and the incidence ...... s with immune thrombocytopenia
@ast
Splenectomy and the incidence ...... s with immune thrombocytopenia
@en
prefLabel
Splenectomy and the incidence ...... s with immune thrombocytopenia
@ast
Splenectomy and the incidence ...... s with immune thrombocytopenia
@en
P2093
P2860
P921
P1433
P1476
Splenectomy and the incidence ...... s with immune thrombocytopenia
@en
P2093
Ann Brunson
Richard H White
Soames Boyle
P2860
P304
P356
10.1182/BLOOD-2012-12-467068
P407
P577
2013-05-01T00:00:00Z